世界の結合型ワクチン市場2020:製造企業別、地域別、種類別、用途別、市場予測2025

GlobalInfoResearchが発行した調査報告書(GIR20OC03309)
◆英語タイトル:Global Conjugate Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20OC03309
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年10月(※2024年版があります。お問い合わせください。)
◆ページ数:101
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本書では、結合型ワクチンの世界市場を調査対象にし、結合型ワクチンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(Hibワクチン、髄膜炎菌ワクチン、肺炎球菌ワクチン、その他)、用途別分析(子供、成人)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。
・市場概要
・メーカー情報:Pfizer、Zhifei Biologic、Merck、GSK、Bharat Biotech、Sanofi、Royal (Wuxi) Bio-Pharmaceutical、Walvax Biotechnology
・メーカー別販売量、売上、市場シェア
・結合型ワクチンの地域別市場分析
・結合型ワクチンの北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・結合型ワクチンのヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・結合型ワクチンのアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・結合型ワクチンの南米市場規模2015-2020:ブラジル、アルゼンチンなど
・結合型ワクチンの中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・結合型ワクチンの種類別市場規模2015-2020:Hibワクチン、髄膜炎菌ワクチン、肺炎球菌ワクチン、その他
・結合型ワクチンの用途別市場規模2015-2020:子供、成人
・結合型ワクチンの世界市場予測2021-2025:地域別、種類別、用途別
・販売チャンネル・代理店分析
・調査の結果・結論
【レポートの概要】

Market Overview
The global Conjugate Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.1% in the forecast period of 2020 to 2025 and will expected to reach USD 10930 million by 2025, from USD 9687.6 million in 2019.

The Conjugate Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Conjugate Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Conjugate Vaccine market has been segmented into
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others

By Application, Conjugate Vaccine has been segmented into:
Children
Adult

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Conjugate Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Conjugate Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Conjugate Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Conjugate Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Conjugate Vaccine Market Share Analysis
Conjugate Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Conjugate Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Conjugate Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Conjugate Vaccine are:
Pfizer
Zhifei Biologic
Merck
GSK
Bharat Biotech
Sanofi
Royal (Wuxi) Bio-Pharmaceutical
Walvax Biotechnology

Among other players domestic and global, Conjugate Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Conjugate Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Conjugate Vaccine, with price, sales, revenue and global market share of Conjugate Vaccine in 2018 and 2019.
Chapter 3, the Conjugate Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Conjugate Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Conjugate Vaccine market forecast, by regions, type and end users, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Conjugate Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Conjugate Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Conjugate Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Hib Vaccine
1.2.3 Meningococcal Vaccine
1.2.4 Pneumococcal Vaccine
1.2.5 Others
1.3 Market Analysis by End Users
1.3.1 Overview: Global Conjugate Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Children
1.3.3 Adult
1.4 Overview of Global Conjugate Vaccine Market
1.4.1 Global Conjugate Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Conjugate Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Zhifei Biologic
2.2.1 Zhifei Biologic Details
2.2.2 Zhifei Biologic Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Zhifei Biologic SWOT Analysis
2.2.4 Zhifei Biologic Product and Services
2.2.5 Zhifei Biologic Conjugate Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Conjugate Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GSK SWOT Analysis
2.4.4 GSK Product and Services
2.4.5 GSK Conjugate Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bharat Biotech
2.5.1 Bharat Biotech Details
2.5.2 Bharat Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bharat Biotech SWOT Analysis
2.5.4 Bharat Biotech Product and Services
2.5.5 Bharat Biotech Conjugate Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Conjugate Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Royal (Wuxi) Bio-Pharmaceutical
2.7.1 Royal (Wuxi) Bio-Pharmaceutical Details
2.7.2 Royal (Wuxi) Bio-Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Royal (Wuxi) Bio-Pharmaceutical SWOT Analysis
2.7.4 Royal (Wuxi) Bio-Pharmaceutical Product and Services
2.7.5 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Walvax Biotechnology
2.8.1 Walvax Biotechnology Details
2.8.2 Walvax Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Walvax Biotechnology SWOT Analysis
2.8.4 Walvax Biotechnology Product and Services
2.8.5 Walvax Biotechnology Conjugate Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Conjugate Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Conjugate Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Conjugate Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Conjugate Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Conjugate Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Conjugate Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Conjugate Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Conjugate Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Conjugate Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Conjugate Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Conjugate Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Conjugate Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Conjugate Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Conjugate Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Conjugate Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Conjugate Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Conjugate Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Conjugate Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Conjugate Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Conjugate Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Conjugate Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Conjugate Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Conjugate Vaccine Sales and Growth Rate (2015-2020)
6.4 France Conjugate Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Conjugate Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Conjugate Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Conjugate Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Conjugate Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Conjugate Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Conjugate Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Conjugate Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Conjugate Vaccine Sales and Growth Rate (2015-2020)
7.5 India Conjugate Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Conjugate Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Conjugate Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Conjugate Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Conjugate Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Conjugate Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Conjugate Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Conjugate Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Conjugate Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Conjugate Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Conjugate Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Conjugate Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Conjugate Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Conjugate Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Conjugate Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Conjugate Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Conjugate Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Conjugate Vaccine Price by Type (2015-2020)
11 Global Conjugate Vaccine Market Segment by End Users
11.1 Global Conjugate Vaccine Sales Market Share by End Users (2015-2020)
11.2 Global Conjugate Vaccine Revenue Market Share by End Users (2015-2020)
11.3 Global Conjugate Vaccine Price by End Users (2015-2020)
12 Market Forecast
12.1 Global Conjugate Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Conjugate Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Conjugate Vaccine Market Forecast (2021-2025)
12.2.2 Europe Conjugate Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Conjugate Vaccine Market Forecast (2021-2025)
12.2.4 South America Conjugate Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Conjugate Vaccine Market Forecast (2021-2025)
12.3 Conjugate Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Conjugate Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Conjugate Vaccine Market Share Forecast by Type (2021-2025)
12.4 Conjugate Vaccine Market Forecast by End Users (2021-2025)
12.4.1 Global Conjugate Vaccine Sales Forecast by End Users (2021-2025)
12.4.2 Global Conjugate Vaccine Market Share Forecast by End Users (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の結合型ワクチン市場2020:製造企業別、地域別、種類別、用途別、市場予測2025(Global Conjugate Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。